person · Reporting owner
Simhambhatla Murthy V
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 27, 2015 | March 03, 2015 |
| Evolus, Inc.EOLS · Entity 5341 | Director · See Remarks | February 07, 2018 | February 07, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 27, 2015 · Filed March 03, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 57,575 |
Reported balance
After 2015-02-27 transaction · row 1
1 source rowRow 1 · 2015-02-27 · Tax withholding · Disposed 5,709 · Balance 57,575 |
Evolus, Inc.
Report date February 07, 2018 · Filed February 07, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,224 |
Reported balance
Holding disclosure · report date 2018-02-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 100,224 F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the two year anniversary of the Issuer's initial public offering under the Securities Act of 1933, as amended, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the Issuer. F2: Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.98 · Expires 2028-01-06 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2018-02-07 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018. F3: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the two year anniversary of the Issuer's initial public offering under the Securities Act of 1933, as amended, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the Issuer.
F2: Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018.
F3: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2015 Filed Mar 3, 2015 22:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,709 | $47.61 | $271,805.49 |
DisclosureSEC source: 0001179110-15-004038 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,575 Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 127,436 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003331 · edgar.xml · derivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,436 Underlying: Common shares · 127,436 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,479 on 2/20/16, 42,478 on 2/20/17, and 42,479 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 18,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003331 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,284 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2015 Filed Feb 19, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 172 | $46.41 | $7,982.69 |
DisclosureSEC source: 0001179110-15-002940 · edgar.xml · nonDerivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,199 Read SEC document |
| February 17, 2015 Filed Feb 19, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 494 | $46.09 | $22,768.46 |
DisclosureSEC source: 0001179110-15-002940 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,371 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,882 | $39.79 | $114,674.78 |
DisclosureSEC source: 0001179110-14-004319 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,865 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 112,668 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003630 · edgar.xml · derivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,668 Underlying: Common shares · 112,668 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,556 on 2/21/2015, 37,556 on 2/21/2016, and 37,556 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 18,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003630 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,747 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 306 | $38.81 | $11,875.86 |
DisclosureSEC source: 0001179110-14-003075 · edgar.xml · nonDerivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,344 Read SEC document |
| February 17, 2014 Filed Feb 19, 2014 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 485 | $38.81 | $18,822.85 |
DisclosureSEC source: 0001179110-14-003075 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,650 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 402 | $34.78 | $13,982.77 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · nonDerivative · entry 5 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,135 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 276 | $35.08 | $9,682.08 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · nonDerivative · entry 4 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,537 Read SEC document |
| February 18, 2013 Filed Feb 20, 2013 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 314 | $35.08 | $11,015.12 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · nonDerivative · entry 3 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,813 Read SEC document |
| February 17, 2013 Filed Feb 20, 2013 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 442 | $35.08 | $15,505.36 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · nonDerivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,127 Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 119,700 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · derivative · entry 6 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,700 Underlying: Common shares · 119,700 shares Expires 2023-02-14 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,900 on 2/15/2014, 39,900 on 2/15/2015, and 39,900 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.